| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/15/1994 | US5286849 Purification of factor IX |
| 02/15/1994 | US5286847 Replacing the arginine residue with glycine at position 11 of the mature form; reduced bioactivity without loss of receptor binding affinity |
| 02/15/1994 | US5286739 Administering arginine-free mixture of amino acids |
| 02/15/1994 | US5286731 Method of treating immunoinflammatory bowel disease |
| 02/15/1994 | US5286730 Administering rapamycins for skin disorders |
| 02/15/1994 | US5286716 Inhibitor of the proliferation of endothelial cells |
| 02/15/1994 | US5286715 New adamantyl comprising tripeptides, derivatives and hydrochlorides thereof, their preparation and use |
| 02/15/1994 | US5286714 Synthetic isohirudins with improved stability |
| 02/15/1994 | US5286648 Culture of Streptosporangium carneum or mutants |
| 02/15/1994 | US5286647 Human-human hybridomas for neoplasms |
| 02/15/1994 | US5286645 Source of heparin binding and non-heparin binding growth factors |
| 02/15/1994 | US5286643 Rat osteosarcoma cell line OSR-8 |
| 02/15/1994 | US5286642 Rat osteosarcoma cell line OSR5TR2 |
| 02/15/1994 | US5286487 Covalent angiogenin/RNase hybrids |
| 02/15/1994 | US5286482 Methods and compositions for inducing monocyte cytotoxicity |
| 02/15/1994 | EP0591458A4 Improved process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates. |
| 02/15/1994 | CA2101417A1 Prophylactic and therapeutic treatment of alzheimer's disease |
| 02/15/1994 | CA1327096C Peptides corresponding to antigenic and immunogenic determinants of major neutralizing proteins of rotaviruses |
| 02/15/1994 | CA1327095C Synthetic peptides derived from the alpha-subunit of human glycoprotein hormones |
| 02/15/1994 | CA1327002C Elaboration of host defense mediators into biological fluids by systemic dsrna treatment |
| 02/15/1994 | CA1327001C Topically active compositions of double-stranded rnas |
| 02/15/1994 | CA1326999C Double-stranded rna correction of abnormalities in circulating immune complexes and monocyte function |
| 02/15/1994 | CA1326996C Preparing process of physiologically active substance with anticancer effect and substance obtained thereby |
| 02/15/1994 | CA1326995C Cyclosporin compositions |
| 02/15/1994 | CA1326994C Proteinase inhibitors for treatment of gastrointestinal ulcer disease |
| 02/10/1994 | DE4226340A1 DNA encoding aphrodisin with an N-terminal signal peptide |
| 02/10/1994 | DE4226109A1 Use of high doses of acetyl salicylic acid - to inhibit the proliferation of smooth muscle cells by inhibiting migration from the media to the intima after vascular injury |
| 02/10/1994 | DE4226102A1 Balhimycin glycopeptide derivs. - with good antibacterial properties, esp. against gram positive bacteria, including methicillin resistant Staphylococci |
| 02/10/1994 | DE4225569A1 Neue Sonde zur Tumordiagnostik oder Tumortherapie New probe for tumor diagnosis and tumor therapy |
| 02/09/1994 | EP0582459A2 Production of microcapsules of water-soluble drugs |
| 02/09/1994 | EP0582239A1 Pharmaceutical and/or cosmetic preparation and the use of such a preparation |
| 02/09/1994 | EP0582186A1 Process for producing solid pharmaceutical dosage forms with an extended two-stage release |
| 02/09/1994 | EP0582143A1 Methods for detecting Alzheimer's disease |
| 02/09/1994 | EP0581967A1 Protein with novel pharmacological characteristic |
| 02/09/1994 | EP0581899A1 Improved process for the preparation of 1s-(1r*, 2s*, 3r*)]-n-(4-(morpholinylsulfonyl)-l-phenylalanyl-3-(2-amino-4-thiazolyl)-n- (1-cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-l-alaninamide |
| 02/09/1994 | EP0581856A1 Method of preventing nmda receptor complex-mediated neuronal damage |
| 02/09/1994 | EP0581836A1 Hybrid transposon with a pt-operon, plasmids and bacterial strains therefor |
| 02/09/1994 | EP0581803A1 Compositions and methods of treatment of a variety of disorders utilizing etianate and agonists thereof |
| 02/09/1994 | EP0366770B1 Liposomes coupled to hormones |
| 02/09/1994 | EP0343227B1 Selective removal of immune complexes |
| 02/09/1994 | CN1081716A Recombiant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv infection |
| 02/09/1994 | CN1081715A Stem cell proliferation factor |
| 02/09/1994 | CN1081682A 甾类衍生物 Steroid derivatives |
| 02/08/1994 | US5284999 DNA encoding a pituitary-specific thyroid hormone receptor |
| 02/08/1994 | US5284937 Antivirals, antitumor agents and immunomodulators |
| 02/08/1994 | US5284933 Fusion protein linked to affinity protein having two or more neighboring histidines |
| 02/08/1994 | US5284931 Intercellular adhesion molecules, and their binding ligands |
| 02/08/1994 | US5284876 Method of treating tardive dyskinesia using dopaminergic agents of prodrugs of therapeutic agents |
| 02/08/1994 | US5284849 Renin inhibitors |
| 02/08/1994 | US5284835 Use of dilinoleoylphosphatidylcholine (DLPC) for treatment and prevention of cirrhosis and fibrosis in the liver |
| 02/08/1994 | US5284832 For treating anemia |
| 02/08/1994 | US5284830 Stimulating cartilage repair |
| 02/08/1994 | US5284829 Synthetic tetrapeptides for the prevention of schistosome parasite infection |
| 02/08/1994 | US5284828 Peptide compound and its preparation |
| 02/08/1994 | US5284827 Systemic treatment of metastatic cancer with platelet factor 4 |
| 02/08/1994 | US5284826 Treating transplant rejection and autoimmune diseases |
| 02/08/1994 | US5284756 Treatment of bone disorders |
| 02/08/1994 | US5284755 DNA encoding leukemia inhibitory factor receptors |
| 02/08/1994 | US5284751 Detecting thrombi, clotting disorders |
| 02/08/1994 | US5284664 Administering mammalian liver extract |
| 02/08/1994 | US5284657 Oligopeptide in cosolvent system fo alcohol and transport enhancing essential oil or acid |
| 02/08/1994 | US5284656 Pulmonary administration of granulocyte colony stimulating factor |
| 02/08/1994 | CA2103536A1 Peptides capable of inhibiting the activity of hiv protease, their preparation and their use |
| 02/08/1994 | CA1326940C Purification of lfa-3 |
| 02/08/1994 | CA1326817C Promotion of healing of meniscal tissue |
| 02/08/1994 | CA1326816C Water-insolubilized cytokines |
| 02/06/1994 | CA2101878A1 Platelet increasing-agent |
| 02/06/1994 | CA2101868A1 Granulocyte-binding antibody constructs, their preparation and use |
| 02/06/1994 | CA2101586A1 Ampa-binding human glur4 receptors |
| 02/04/1994 | CA2101357A1 Veterinary method |
| 02/03/1994 | WO1994002627A1 Recombinant antibody against human interleukin-1 |
| 02/03/1994 | WO1994002626A1 Immunological conjugates of ompc and hiv-specific selected principal neutralization epitopes |
| 02/03/1994 | WO1994002614A1 PEPTIDES THAT MIMIC gp120 HIV EPITOPE |
| 02/03/1994 | WO1994002611A2 Recombinant human erythropoietin with altered biological activity |
| 02/03/1994 | WO1994002610A1 Method of intracellular binding of target molecules |
| 02/03/1994 | WO1994002606A1 Inhibition of retroviral expression by interferon-induced cellular genes and proteins |
| 02/03/1994 | WO1994002605A1 Dna encoding the human a1 adenosine receptor |
| 02/03/1994 | WO1994002602A1 Generation of xenogeneic antibodies |
| 02/03/1994 | WO1994002595A1 Method and reagent for treatment of animal diseases |
| 02/03/1994 | WO1994002589A1 Mammalian cationic proteins having lipopolysaccharide binding and anti-coagulant activity |
| 02/03/1994 | WO1994002512A1 Carboxy terminal il-6 muteins |
| 02/03/1994 | WO1994002511A1 Calcium channel blocking polypeptide from agelenopsis aperta |
| 02/03/1994 | WO1994002510A2 Analogs of pth |
| 02/03/1994 | WO1994002509A1 Hla-dr3 blocking peptides and their use in the treatment of hla-dr3 associated autoimmune diseases. |
| 02/03/1994 | WO1994002507A2 Methods for detecting pre-clinical iddm |
| 02/03/1994 | WO1994002505A1 Compounds which inhibit hiv replication |
| 02/03/1994 | WO1994002504A1 Cytotoxic t-lymphocyte antigen as cysteine protease inhibitor |
| 02/03/1994 | WO1994002488A1 BIS-STAUROSPORINE AND K-252a DERIVATIVES |
| 02/03/1994 | WO1994002445A1 Non-peptidic surrogates of the ldv sequence and their use in the treatment of inflammation, autoimmune diseases and tumour progression |
| 02/03/1994 | WO1994002182A1 A two component fibrin-glue composition for improving in vitro fertilization |
| 02/03/1994 | WO1994002175A1 Alleviation of symptoms associated with inflammatory disease states |
| 02/03/1994 | WO1994002172A1 Blockade of protein c activation reduces microvascular surgical blood loss |
| 02/03/1994 | WO1994002166A1 Nutritional product for persons having a neurological injury |
| 02/03/1994 | WO1994002165A1 Blood coagulation normalizer containing tcf-ii as active ingredient |
| 02/03/1994 | WO1994002164A1 Granulocyte colony-stimulating factor solution delivery method |
| 02/03/1994 | WO1994002163A1 Neuromedin b receptor antagonists |
| 02/03/1994 | WO1994002162A1 Peptide medicaments for treating disease |
| 02/03/1994 | WO1994002148A1 Novel bioactive compositions, preparation and use thereof |
| 02/03/1994 | WO1994002108A1 Chemotherapy for cancer |
| 02/03/1994 | WO1994002105A1 Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it |